Denervation Response Prediction Using Baseline Patient Parameters

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing renal denervation therapies for hypertension have variable effectiveness among patients, with some patients not responding well due to differing physiological characteristics, making it difficult for clinicians and patients to assess potential benefits and risks.

Innovation Solution

A computing device uses a computational model to predict the change in blood pressure of a patient before denervation therapy, incorporating patient parameters and weighting coefficients derived from a large patient population, providing a non-invasive and accurate prediction of therapy response.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If percutaneous renal denervation procedure is performed to treat hypertension, then blood pressure reduction may be achieved in some patients, but not all patients respond well and some are non-responders

Engineering Contradiction:
Improvetherapy effectivenessVSAvoidpatient responsiveness variation
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies preliminary action by measuring baseline sympathetic nerve activity before denervation therapy to predict patient responsiveness. This pre-assessment allows clinicians to identify likely responders versus non-responders before committing to the invasive procedure, thereby improving therapy reliability by selecting appropriate candidates in advance.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent implements feedback by using baseline sympathetic nerve activity measurements to inform treatment decisions. The measured baseline activity serves as feedback about patient characteristics that predict treatment outcome, allowing the treatment approach to be adapted based on individual patient physiology rather than applying a one-size-fits-all approach.

Inventive Principle:
Principle #23Feedback

2Measurement precision

If denervation therapy is delivered to reduce sympathetic nerve activity, then blood pressure reduction may occur, but the extent of reduction varies substantially among patients

Engineering Contradiction:
Improveblood pressure reduction predictionVSAvoidpredictive model complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces complex clinical judgment and trial-and-error approaches with an automated computational model that processes baseline measurements to predict blood pressure reduction. This substitution of mechanical/computational systems for human decision-making improves measurement precision in predicting outcomes while managing the complexity through algorithmic processing rather than manual assessment.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent utilizes parameter changes by measuring baseline sympathetic nerve activity as a key parameter that correlates with treatment response. By identifying and measuring this specific physiological parameter before treatment, the model can predict the magnitude of blood pressure reduction, transforming a variable outcome into a predictable result based on measurable parameters.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If invasive denervation procedure is performed without predicting responsiveness, then treatment may be delivered, but patient discomfort and healthcare resources are wasted on ineffective procedures

Engineering Contradiction:
Improvehealthcare efficiencyVSAvoidpatient discomfort from ineffective procedure
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by performing non-invasive baseline sympathetic nerve activity measurements before the invasive denervation procedure. This pre-screening identifies patients likely to benefit from treatment, preventing unnecessary invasive procedures on non-responders and thereby eliminating patient discomfort and resource waste associated with ineffective treatments.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent introduces an intermediary predictive model that sits between the decision to treat and the actual invasive procedure. This intermediary assessment tool evaluates baseline parameters and predicts treatment outcomes, serving as a mediator that filters out unlikely responders before they undergo invasive procedures, thus improving healthcare efficiency and reducing patient suffering.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS20250387080A1Estimating responsiveness to denervation therapy
Publication Date: 2025.12.25 MEDTRONIC IRELAND MFG UNLIMITED CO
  • US20250387080A1 patent drawing
  • US20250387080A1 patent drawing
  • US20250387080A1 patent drawing

AI summary

An example computing system includes a memory and one or more processors coupled to the memory. The one or more processors obtain values for a plurality of patient parameters of a patient with hypertension that relate to a physiological condition of the patient. Before delivery of denervation therapy to the patient, the one or more processors determine, using a computational model, a predicted change in blood pressure of the patient if the denervation therapy is delivered based on the values of the plurality of patient parameters based on the values of the plurality of patient parameters. The one or more processors output, responsive to determining the predicted change in blood pressure of the patient, an indication associated with the predicted change in blood pressure of the patient.